Business Summary
Neogene Therapeutics BV is a Netherlands-based global, clinical-stage biotechnology company. The Company is engaged in development, and manufacturing of engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. It delivers a tailored therapy based on neoantigen-targeting TCR genes that target neoantigens found in an individual patient’s tumor. These TCR genes are engineered into patient-derived T cells based on in-house developed T cell engineering technologies with the goal of eliciting and durable responses in a variety of solid tumor indications.
Country of Incorporation
Netherlands
Incorporation Date
-
Business Sector
Pharmaceuticals & Medical Research
Company Address
Science Park 106